[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362139-105":59,"doc-detail-362139-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comparative-transcriptomic-analysis-identifies-predictive-biomarkers-of-pathological-complete-response-in-triple-negative-breast-cancer-research-findings","Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer - Research Findings","","Pathologic complete response (pCR) after neoadjuvant chemotherapy is a key prognostic marker in triple-negative breast cancer, yet dependable predictive biomarkers are scarce. Tumor RNA sequencing was performed on 16 TNBC patients treated with NACT, including 5 pCR and 11 non-pCR cases, and results were validated in an independent cohort. Differential expression and integrative analyses identified gene candidates with therapeutic relevance. A validated 15-gene signature associated with pCR supports improved treatment stratification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparative-transcriptomic-analysis-identifies-predictive-biomarkers-of-pathological-complete-response-in-triple-negative-breast-cancer-research-findings/362139/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparative-transcriptomic-analysis-identifies-predictive-biomarkers-of-pathological-complete-response-in-triple-negative-breast-cancer-research-findings/362139.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does pathologic complete response (pCR) indicate in triple-negative breast cancer?","Question",{"text":112,"@type":113},"In triple-negative breast cancer, pCR after neoadjuvant chemotherapy is a strong prognostic indicator linked to improved outcomes. It reflects absence of invasive disease after treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were predictive biomarkers identified in this study?",{"text":117,"@type":113},"Tumor samples from patients treated with neoadjuvant chemotherapy were analyzed using RNA sequencing. Differentially expressed genes were detected, compared across cohorts, and assessed for consistent patterns related to pCR.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the main outcome of the gene expression signature analysis?",{"text":121,"@type":113},"The study identified and validated a 15-gene signature associated with pCR across independent cohorts. These genes may help guide personalized treatment decisions and targeted therapeutic development.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362139,1790710369,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","doi: 10.21873/cgp.20561  \nComparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer  \nFANG-MING CHEN1*, CHUNG-LIANG LI1*, MEI-REN PAN2,3, YUN-CIAN HUANG4, LI-JU HUANG5, SIN-HUA MOI2,5,6,7, SHU-JYUAN CHANG2, PING-FU YANG1, CHIEH-NI KAO1, JUNG-YU KAN1, LI-KUN KO1, HIDENOBU TAKAHASHI1, CHIA-YU KUO1, SHEN-LIANG SHIH1, MING-FENG HOU1, YI-HSIUNG LIN8 and CHI-WEN LUO1,9  \n1 Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n2Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n3 Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.; 4Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n5 Department of Medical Research and Development, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, R.O.C.;  \n6 Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n7Center of Applied Genomics, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n8Center for Lipid Biosciences, Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n9 Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan, R.O.C.  \nAbstract  \nBackground/Aim: Pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) is a strong prognostic indicator in triple-negative breast cancer (TNBC). However, reliable predictive biomarkers for pCR remain limited. This study aimed to identify gene expression signatures associated with pCR in TNBC to facilitate more precise treatment stratification.  \nMaterials and Methods: Tumor samples from 16 TNBC patients treated with NAC atthe Kaohsiung Medical University Hospital (KMUH) were analyzed, including 5 pCR and 11 non-pCR cases. RNA sequencing (RNA-seq) was performed, and differentially expressed genes (DEGs) were identified using DESeq2 (|log2FC| ≥2, adjusted p\u003C0.05) . Gene expression profiles were compared with a validation cohort of 27 NAC-responsive TNBC cases from The Cancer continued  \n*These Authors contributed equally to this work.  \n✉ Chi-Wen Luo, Department of Surgery, Kaohsiung Medical University Hospital, 100 Tzyou 1st Rd, Kaohsiung 807, Taiwan,  \nR.O.C. Tel: +886 73121101 ext2260, Fax: +886 73165011, e-mail: [cwlo0623@gmail.com](cwlo0623@gmail.com)  \nReceived September 4, 2025 | Revised September 24, 2025 | Accepted October 8, 2025  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nGenome Atlas (TCGA) . Overlapping DEGs were identified using Venn diagram analysis, and drug-gene interaction databases were queried to explore therapeutic relevance.  \nResults: In the KMUH cohort, 175 DEGs were identified, including 146 up-regulated and 29 down-regulated genes in non-pCR tumors. Fifteen DEGs demonstrated consistent differential expression patterns between KMUH and TCGA datasets, showing enrichment in pCR samples. These genes may serve as predictive biomarkers for NAC response. Notably, several of these genes are potentially druggable, suggesting opportunities for targeted therapy inchemoresistant TNBC.  \nConclusion: We identified and validated a 15 gene signature associated with pCR inTNBC across independent cohorts. These findings offer a promising basis for improving patient stratification, guiding treatment decisions, and developing targeted therapies for NAC-resistant TNBC.  \nKeywords: Triple-negative","cbCaik65DJ4cjQag","https://ap.wps.com/l/cbCaik65DJ4cjQag","pdf",2822730,15,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction\n## Triple-negative breast cancer and treatment challenges\n## Neoadjuvant chemotherapy and pCR as a prognostic marker\n## Need for predictive biomarkers\n## Transcriptomic approaches with RNA-seq","[{\"question\":\"What does pathologic complete response (pCR) indicate in triple-negative breast cancer?\",\"answer\":\"In triple-negative breast cancer, pCR after neoadjuvant chemotherapy is a strong prognostic indicator linked to improved outcomes. It reflects absence of invasive disease after treatment.\"},{\"question\":\"How were predictive biomarkers identified in this study?\",\"answer\":\"Tumor samples from patients treated with neoadjuvant chemotherapy were analyzed using RNA sequencing. Differentially expressed genes were detected, compared across cohorts, and assessed for consistent patterns related to pCR.\"},{\"question\":\"What was the main outcome of the gene expression signature analysis?\",\"answer\":\"The study identified and validated a 15-gene signature associated with pCR across independent cohorts. These genes may help guide personalized treatment decisions and targeted therapeutic development.\"}]","Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer - Research Findings | PDF",1790146564,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbd338cd04c9344e8d2432970f3502ad.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03f493b55e14a4c4f6ac5969d0a9de6c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf2c0701775199450f96aee28195b417.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/148e3996bebe6fc2dd87f09657ad7e7c.webp",980,1306]